Neo-Ceftazidime Pediatric 250mg Vial from Japan
Pediatric-strength 250mg ceftazidime vial for neonatal sepsis treatment. HTS 3004.20.00.72 as measured dose containing ceftazidime salts for prophylactic/therapeutic use in retail packs. Lower dose for weight-based dosing.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include age-appropriate dosing info and contraindication labels
• Source from GMP-certified facilities with pediatric exclusivity data
• Avoid adult strength mislabeling for correct pediatric classification